Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the “Best of JAMA and NEJM” session - RADNOR, Pa., ...
Dementia poses an increasing global health challenge, and the introduction of new drugs with diverse activity profiles ...
Nektar Therapeutics today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the American College of Allergy, Asthma & Immunology (ACAAI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback